# Stellular Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/stellular-bio

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.stellularbio.com
- Total disclosed funding: $72M
- Latest round: Series B (Oct 19, 2021)
- Investors on record: 9

## About

Established in 2014 and based in Massachusetts, US, Stellular Bio, Inc., formerly known as Platelet BioGenesis, Inc., operates as a biotechnology company that provides platelet-derived regenerative biologic therapies for ocular surface disease.

## Funding rounds

- Series B, Oct 19, 2021, $35M — Qiming Venture Partners, Oxford Finance, Ziff Capital Partners, K2 HealthVentures, SymBiosis Capital Management
- Series A, Jun 5, 2019, $26M — Qiming Venture Partners, eCoast Angel, Nest.Bio Ventures, Ziff Capital Partners
- Series A, May 25, 2017, $10M — Vivo Capital, Qiming Venture Partners, eCoast Angel, Virtus Inspire Ventures

## Investors

- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A, Series B
- eCoast Angel — Series A
- Virtus Inspire Ventures (https://capitalatlas.ai/funds/virtus-inspire-ventures) — Series A
- Nest.Bio Ventures (https://capitalatlas.ai/funds/nest-bio-ventures) — Series A
- Ziff Capital Partners — Series A, Series B
- Oxford Finance — Series B
- K2 HealthVentures (https://capitalatlas.ai/funds/k2-healthventures) — Series B
- SymBiosis Capital Management (https://capitalatlas.ai/funds/symbiosis-capital-management) — Series B